|
|||||
|
|
SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation? |
|
| Institution: | 1. Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, United States;2. Texas Biomedical Research Institute, Southwest National Primate Research Center, San Antonio, TX 78227, United States |
| Abstract: | |
| Keywords: | SARS-CoV2 Rhesus macaque Cannabinoids Inflammation Cytokine Lung |
| 本文献已被 ScienceDirect 等数据库收录！ | |